相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7
Jingnan Pi et al.
CANCER RESEARCH (2021)
Direct Regulation of DNA Repair by E2F and RB in Mammals and Plants: Core Function or Convergent Evolution?
Swarnalatha Manickavinayaham et al.
CANCERS (2021)
The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner
Xiao-Yu Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer
Camille Franchet et al.
CANCERS (2021)
RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8
Kaori Iino et al.
CANCER SCIENCE (2020)
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Tao Liu et al.
NUCLEIC ACIDS RESEARCH (2020)
Inactivation of the Prolyl Isomerase Pin1 Sensitizes BRCA1-Proficient Breast Cancer to PARP Inhibition
Man-Li Luo et al.
CANCER RESEARCH (2020)
METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification
Wei Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou et al.
MOLECULAR CANCER (2020)
METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation
Canfeng Zhang et al.
MOLECULAR CELL (2020)
YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
Xiangxiang Liu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Nadine M. Tung et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
YTHDF1-enhanced iron metabolism depends on TFRC m6A methylation
Jing Ye et al.
THERANOSTICS (2020)
A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair
Zhiwang Song et al.
CELL DEATH & DISEASE (2019)
Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51
Guohong Liu et al.
CELLULAR SIGNALLING (2019)
Functions of N6-methyladenosine and its role in cancer
Liuer He et al.
MOLECULAR CANCER (2019)
Harnessing DNA Double-Strand Break Repair for Cancer Treatment
Anika Trenner et al.
FRONTIERS IN ONCOLOGY (2019)
Metformin overcomes resistance to cisplatin in triple-negative breast cancer (TNBC) cells by targeting RAD51
Jung Ok Lee et al.
BREAST CANCER RESEARCH (2019)
Homologous recombination and the repair of DNA double-strand breaks
William Douglass Wright et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
Yinghua Zhu et al.
NATURE COMMUNICATIONS (2018)
RNA m6A methylation regulates the ultraviolet-induced DNA damage response
Yang Xiang et al.
NATURE (2017)
Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition
Lu Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition
Liping Ye et al.
ONCOTARGET (2016)
Regulators of homologous recombination repair as novel targets for cancer treatment
Malgorzata Krajewska et al.
FRONTIERS IN GENETICS (2015)
DNA replication and homologous recombination factors: acting together to maintain genome stability
Antoine Aze et al.
CHROMOSOMA (2013)
Repair of Strand Breaks by Homologous Recombination
Maria Jasin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Homologous recombination in DNA repair and DNA damage tolerance
Xuan Li et al.
CELL RESEARCH (2008)
DNA-damage response control of E2F7 and E2F8
L. Panagiotis Zalmas et al.
EMBO REPORTS (2008)
分享论文
